EMERGENCE-BIO - Emergence et maturation de projets de biotechnologie et de Technologie pour la santé à fort potentiel de valorisation
Développement de l'anticorps BY40, inhibiteur de l'activité des cellules T régulatrices – REGHTER
Project coordination
Armand BENSUSSAN (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 293,737 euros
Beginning and duration of the scientific project:
- 18 Months
